specific for urinary Ape A-I. In the assay 96-well microplates are used, and serum HDL as standard.
The method's specificity, sensitivity, and accuracy are defined from results of studies of concentrations of Ape A-I in urine from healthy subjects and from a group of nephrotic patients.
MaterIals and Methods

Blood and Urine Samples
Twenty-four-hour urine specimens were collected from 50 ostensibly healthy subjects, ages 17-56 years, and 10 adult patients (six men and four women), ages 23-50 years, with biopsy-proven glomerular disease. None of the healthy subjects was taking any drugs during the study. During the 24 h of urine collection, we collected a 10-mL blood sample from each subject, who had fasted overnight. All urine samples were collected at 4 #{176}C without preservatives. Aliquots of serum and urine were stored at 4#{176}C for immediate use or at -70 #{176}C for subsequent analysis.
Timed urine specimens were also collected from healthy volunteers (four men, two women) at different times of the day (first void, 0800, 1200, 1600, and 2000 hours). Fluid intake was recorded during collection of these samples. Results For three mine pools tested, the intra-assay and interassay coefficients of variation (CV) ranged from 6.0 to 8.9%, and 8.7 to 11.6%, respectively (Table 2) . Analytical recovery (Table 3) x iO 'Unnes were diluted twofold for normal subjects and 500-fold for patients with proteinurla; results, expressed as means ± SD, are corrected for dilution.
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